Clinical Trial

Urinary Proteomics Combined With Home Blood Pressure Telemonitoring for Health Care Reform

Study acronym: UPRIGHT-HTM
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated March 6, 2020 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
UPRIGHT-HTM will compare risk stratification, treatment efficiency and health economic outcomes of a diagnostic approach based on home blood pressure telemonitoring combined with urinary proteomic profiling with home blood pressure telemonitoring alone
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT04299529
Lead Sponsor KU Leuven
Collaborators: Alliance for the Promotion of Preventive Medicine
Conditions Protein Deregulation, Blood Pressure, Health Care Utilization, Cost Effectiveness, Patient Empowerment
Enrollment 1,000 participants
Start Date 2020-04-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2020-03-06